Pharma News
-
Universities get $15mn from Teva for CNS R&D
Pharma | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013
Singapore: Israel-based Teva is undergoing re-organization in order to mitigate lost revenue from increased competition ...Read more
-
NSF brings Secondary Reference Standards to India
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: NSF International, an independent global public health and safety organization which develops standards, and ...Read more
-
Takeda, Resolve to develop, sell autoimmune drugs
Pharma | News | By BioSpectrum Bureau | 0 Comment | 28 Feb, 2013
Singapore: Takeda Pharmaceutical has entered into a partnership with Resolve Therapeutics to develop compounds for the t...Read more
-
Bayer initiates Phase II/III trial of a new compound for Hemophilia A
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore, July 09, 2012: Bayer HealthCare has started to enroll patients in an international Phase II/III trial to eval...Read more
-
GlobalData: Osteoporosis market to be $8 bn
Pharma | Analysis | By BioSpectrum Bureau | 0 Comment | 08 Mar, 2013
Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the ...Read more
-
Cipla gets drug pricing breather from Delhi Court
Pharma | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013
Singapore: India's Delhi High Court has extended the operation of its earlier order asking the central government not t...Read more
-
Malaysia a hotbed for medical tourism'
Pharma | Analysis | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2014
Singapore: Medical tourism, easy regulatory guidelines, a lack of strict price regulation and an increasing elderly popu...Read more
-
R-Tech Ueno loses case against Takeda
Pharma | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2012
Singapore: The International Court of Arbitration, International Chamber of Commerce, has issued its arbitral award in t...Read more
-
APAC ovarian cancer drug market to grow modestly'
Pharma | Analysis | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2015
Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...Read more
-
China Botanic reports Q3 2012 results
Pharma | Company results | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2012
Singapore: China Botanic Pharmaceutical revealed its financial results for the three months ending July 31, 2012. During...Read more
-
Atrial fibrillation management is suboptimal and unequal
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: New one-year follow-up results from the global RE-LY AF registry shows that 11.7 percent of patients with atr...Read more
-
Deal with Janssen gets Astellas $65 million up-front
Pharma | News | By BioSpectrum Bureau | 0 Comment | 02 Oct, 2012
Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to...Read more
-
Pharma | News | By BioSpectrum Bureau | 0 Comment | 08 Jun, 2012
Singapore: Takeda Pharmaceutical Company acquired URL Pharma through its wholly-owned subsidiary Takeda America Holdings...Read more
-
Indian Government strengthens clinical trials regulations
Pharma | News | By BioSpectrum Bureau | 0 Comment | 14 May, 2012
Bangalore: In a bid to strengthen the regulation and monitoring of clinical trials in the country, the Indian Government...Read more
-
Taiwan approves gout drug febuxostat
Pharma | News | By BioSpectrum Bureau | 0 Comment | 17 May, 2012
Singapore: Taiwan's Department of Health has approved marketing of febuxostat, a novel drug developed for the treatment ...Read more
-
Research and Markets offers new report on China pharma industry
Pharma | News | By BioSpectrum Bureau | 0 Comment | 14 May, 2012
Singapore: Research and Markets has added a report on China Pharmaceutical Machinery Industry to their offering. This r...Read more
-
China Biologics appoint David Gao to additional post of CEO
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
China Biologic Products, one of the leading plasma-based biopharmaceutical companies in the People's Republic of China,...Read more
-
Dishman Pharma records 13.2% growth
Pharma | Company results | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Bangalore: Dishman Pharma has posted a 13.24 percent growth in the fourth quarter of FY12 and reported a consolidated ne...Read more
